Discordance Between Coronary CTA and Stress MPI to high probability of CAD or known CAD, who underwent both S-MPI and CCTA as sequential examinations to clarify the existence of CAD or to determine the treatment strategy. The pretest likelihood of CAD was calculated for patients without known CAD using the clinical pretest risk score suggested by Morise et al. 6 Known CAD, defined as evidence of CAD on previous diagnostic tests or a history of CAD before S-MPI and CCTA, was treated in the same manner as a high probability of CAD. The average interval between the 2 examinations was 29 days (±28 days). Exclusion criteria were unstable angina/acute coronary syndrome, post coronary artery bypass surgery (CABG), atrial fibrillation, renal insufficiency (serum creatinine >2.0 mg/dl) without hemodialysis, known allergy to iodine contrast media, and pregnancy. Those patients who had any cardiac event or underwent percutaneous coronary intervention in the interval were also excluded. The study protocol was approved by the local institutional review board, and all patients gave written informed consent before enrollment.
Coronary CT Angiography
The CCTA examination was performed using a 64-slice MSCT scanner (LightSpeed VCT; GE Medical Systems). In the absence of contraindications, all patients were given a β-blocking medication (metoprolol 50-100 mg orally) 1 h before CT examination. Nitroglycerin was not administered before scanning. Before the helical scan, a non-enhanced prospective ECG-gated scan, prospectively triggered at 75% of the RR interval with 64×1.25 mm collimation, was obtained to measure the coronary calcium score (CCS) and determine the start and end positions of the helical scan. The minimal gantry rotation time was 0.35 s, the tube voltage was 120 kV, the tube current ranged from 280 to 750 mA using ECG modulation, and the pitch ranged from 0.18 to 0.26 depending on the patient's heart rate. A bolus of 0.8 ml/kg (body weight) of contrast agent (Iopamiron 370, Bayer, Germany) was intravenously injected at body weight × 0.08 ml/s, followed by a 20-ml saline solution flush. A region of interest (ROI) was placed in the ascending aorta in a single defined slice. The helical scan was automatically triggered when the attenuation level in the ROI reached baseline over 200 Hounsfield units. Thereafter, scanning was initiated, covering the distance from the tracheal bifurcation to the diaphragmatic side of the heart during a single inspiratory breath-hold for an acquisition time of 5-7 s. For optimal heart phase selection, retrospective ECG gating was used. Retrospective reconstruction of the image data was performed for acquisition of phase images starting from early systole (5% of the R-R interval) and ending at late diastole (95% of the R-R interval) using 5% increments. All images were reconstructed with a display field of view of 25 cm, a standard soft tissue filter as suggested by the manufacturer and an effective slice thickness of 0.625 mm at an increment of 0.625 mm.
CCTA Interpretation
All CCTA images were interpreted by 2 experienced observers blinded to the results of S-MPI. Discrepancies in interpretation were resolved by consensus. The CCTA datasets were analyzed using axial source images, multiplanar reformations, and thin-slab maximum-intensity projections on a remote workstation (Advantage Workstation 4.3; GE Healthcare). The coronary tree was evaluated basically according to a 15-segment model proposed by the American Heart Association (AHA). 7 The intermediate artery, also known as the Ramus artery, was designated as segment 16, if present, and regarded as belonging to the left anterior descending. In each patient, the presence of coronary plaque and stenosis was visually assessed. Coronary arteries were classified into 3 categories: normal, non-obstructive plaque, or obstructive stenosis (>50% luminal narrowing). The total CCS was also determined.
Stress Myocardial Perfusion Imaging
All patients underwent a 1-day ECG-gated stress/rest protocol with symptom-limited exercise stress testing using an ergometer or pharmacologic stress with adenosine (0.14 mg · kg -1 · min -1 for 6 min). In patients who underwent exercise stress testing, over 85% of maximum heart rate was achieved if no stress-induced symptoms or changes on the ECG or blood pressure occurred. A dose of 296 MBq technetium-99m tetrofosmin or technetium-99m sestamibi was injected at rest, and this was followed by stress imaging with injection of a 740-MBq dose. Patients were instructed to withhold β-blocking medications for 48 h before exercise stress, and were instructed to withhold calcium antagonists for 24 h before pharmacologic stress with adenosine. Patients were also told to abstain from caffeine starting the day before adenosine stress testing.
Gated single photon emission computed tomography (SPECT) datasets were acquired with a dual-head detector camera (Infinia; GE Medical Systems, Milwaukee, WI, USA); a low-energy general-purpose collimator; a 20% symmetrical window at 140 keV; a 64×64 matrix; a circular orbit with stepand-shoot acquisition at 5° intervals over 180°; and 30-s/projection for stress imaging and 50-s/projection for rest imaging. An ECG R-wave detector provided a gate to acquire 16 frames per cardiac cycle. For all patients, the summed nongated SPECT datasets were reconstructed on a dedicated workstation (Xeleris, GE Medical Systems), using the filteredback projection method, into short, vertical -long-axis, and horizontal -long-axis slices encompassing the entire left ventricle. Projection images were filtered using a 2D Butterworth filter, order of 8 and a cutoff frequency of 0.4 cycles/cm in principle. In some patients, the parameters were properly adjusted to some extent for better visualization (order, 8-10; cutoff frequency, 0.4-0.5 cycles/cm). In addition, polar maps of perfusion, wall motion, and wall thickening were produced, and left ventricular end-diastolic volume (LVEDV), end-systolic volume, and ejection fraction (LVEF) were calculated using gated SPECT data and commercially available software (Cedars QGS/QPS; Cedars-Sinai Medical Center, Los Angeles, CA, USA). 8
S-MPI Interpretation
S-MPI was judged by 2 experienced observers blinded to the results of CCTA. The myocardium was divided into segments using a 17-segment model described elsewhere. 9 Segmental tracer activities were semiquantitatively categorized using a 5-point grading system (0: normal tracer activity, 1: mildly decreased activity, 2: moderately decreased activity, 3: severely decreased activity and 4: complete defect). Image interpretation using SPECT images (short, vertical-long-azis and horizontal-long-axis slices) with reference to the results of analysis of the polar maps, which were used to assess regional perfusion, wall motion and thickening to improve differentiation between perfusion abnormalities and attenuation artifacts, was visually performed with regard to reversible (ischemia) and fixed (scar) defects. Semiquantitative perfusion scores after stress (SSS; summed stress score) were calculated as previously reported. 10 SSS <4 was considered KIRIYAMA T et al.
a normal S-MPI result. To avoid underestimating perfusion abnormalities in patients with a LMT lesion or balanced 3-vessel disease, postischemic stunning and transient ischemic dilatation (TID) were also assessed. The myocardium was divided into 7 segments according to the American Heart Association criteria, and regional wall motion was scored semiquantitatively using visual inspection of gated SPECT perfusion images in cine mode based on a 4-point grading system (0, normokinesis; 1, mild hypokinesis; 2, severe hypokinesis; 3, akinesis or dyskinesis). Postischemic stunning was defined as the post-stress score ≥1 points greater than the rest score in ≥1 segment, or >5% reduction of LVEF at post-stress scan. TID was defined as the ratio between post-stress and rest LVEDV >1.22 (exercise stress) or 1.36 (pharmacologic stress). 11-13
SPECT/CT Fusion Imaging and Interpretation
To obtain more accurate interpretation of S-MPI, SPECT/CT fusion imaging was performed on a designated workstation (Advantage Workstation 4.3) using the CardIQ Fusion software package (GE Healthcare). All details of the fusion process have been extensively described, validated, and reported elsewhere. 14 In brief, this software provides tools for optimal alignment of axial source SPECT and CT images using the myocardial outlines of SPECT and CT as landmarks and for SPECT image projection on the left ventricular (LV) epicardial surface. The window presets for the color scale projected on the LV epicardium are adopted from the corresponding separate SPECT images and remain unchanged during the fusion process. Additionally, the fusion software facilitates extraction of the aorta and the coronary vessel tree structure from the surrounding tissue. For better visualization of the septal wall, fading of the right ventricle can be achieved using a cardiac transparency tool.
The analysis of the fused 3D SPECT/CT images was performed based on both initial S-MPI and CCTA interpretations. The readers evaluated the relationship between perfusion defects and coronary artery territories to confirm whether an equivocal defect depicted on the initial S-MPI study was a true defect or an artifact. After all interpretations, patients with normal S-MPI results (SSS <4) were confirmed. The coronary morphological information obtained by CCTA was compared with myocardial functional information obtained by S-MPI.
Patient Follow-up
Patient follow-up was performed by checking the medical records and/or telephone interview. Clinical endpoints were (1) death from any cause, (2) cardiac death, (3) non-fatal myocardial infarction, (4) unstable angina requiring hospitalization, and (5) coronary revascularization. Cardiac death was defined as death caused by acute myocardial infarction, ventricular arrhythmias, or refractory heart failure. Nonfatal myocardial infarction was defined based on criteria of typical chest pain, elevated cardiac enzyme levels, and typical changes on the ECG. 15 Unstable angina was defined according to the European Society of Cardiology guidelines as acute chest pain with or without the presence of ECG abnormalities, and negative cardiac enzyme levels. 16 Patients with stable complaints undergoing an early elective revascularization within 60 days after imaging with CCTA or S-MPI were excluded. All patients included in this study were followed for at least 1 year (mean follow-up 29±7 months).
Statistical Analysis
Continuous variables are expressed as means ± SD, and were compared using the 2-tailed unpaired Student's t-test or Mann-Whitney test if the distribution was not normal. Categorical data were compared using the Mann-Whitney test with 2-tailed analysis of variables. P<0.05 was considered to indicate a statistically significant difference.
Results

Patients' Characteristics
Patient characteristics are summarized in Table 1 . The mean age of the study population was 68±11 years (range 46-90 years). Intermediate and high likelihoods for CAD were noted in 25 of the 56 patients (45%), and in 8 (14%) of the 33 patients (59%) without known CAD. The remaining 23 patients (41%) had known CAD, which in this study was dealt with in the same manner as a high likelihood for CAD.
Results of CCTA and S-MPI After Fusion Imaging
During CCTA data acquisition, all patients were in sinus rhythm, and mean heart rate during CT was 56±8 beats/min. Image quality was poor in 5 (9%) patients owing to premature atrial/ventricular contraction in 2 (4%), high heart rate in 1 (2%), and heavily calcified plaques/stent and/or motion artifact in 2 (4%). Excluding these 5 patients, a total of 828 coronary segments were analyzed; 19 segments (2%) were not interpretable because of heavy calcification or motion artifacts. Plaque and stenosis >50% were found in 353 (43%) and 195 (24%) segments, respectively. The average calcium score of the 51 patients with interpretable data was 535±590. Coronary calcium was absent in 7 patients (13%). A calcium score of 1-100 was observed in 4 patients (8%); a score of 101-400 in 16 (33%) patients; and 24 (46%) had a calcium score >400.
An exercise stress test was performed in 34 patients (61%). In 13 (38%) patients, no stress-induced symptoms or changes on ECG or blood pressure occurred and >85% of maximum heart rate was achieved. Normal S-MPI results were observed in 26 patients (46%) on initial interpretation. Six equivocal defects in 5 patients (9%) appeared not to correspond to coronary artery territory based on using fusion imaging, and these defects were considered breast/diaphragmatic artifacts or apical thinning. Summed stress scores <4 were seen in 31 (55%) patients; 4-7 in 7 (13%); 8-11 in 6 (11%); >11 in 12 (21%). Accordingly, 31 (55%) patients with normal S-MPI results (SSS <4) were confirmed. One (3%) of these 31 patients showed postischemic stunning after stress on the QGS, suggesting the potential of balanced disease, while postischemic stunning or TID was observed in 14 (56%) of 25 patients with abnormal S-MPI results.
Comparison of S-MPI and CCTA Results
Among the 5 patients with poor CCTA study, S-MPI was normal (SSS <4) in 1 (20%) and abnormal (SSS >4) in the remaining 4 (80%). After exclusion of these patients, 51 patients had data suitable for analysis. The clinical characteristics and imaging results of 51 patients with and without abnormal MPI are shown in Table 2 . Among the 30 patients with normal S-MPI, only 3 (10%) had completely normal coronary arteries diagnosed by CCTA; 3 (10%) had non-obstructive CAD, and 24 (80%) obstructive CAD. All 21 patients with abnormal S-MPI results had obstructive CAD. There were no significant differences in the proportions of normal coronary, non-obstructive and obstructive CAD between patients with normal and abnormal S-MPI. The average calcium score of the patients with normal and abnormal S-MPI was 498±652 and 587±500, respectively (P=NS).
The proportions of segments with stenosis, LMT lesions, and high-risk CAD (defined as obstructive LMT or 3-vessel disease) among normal and abnormal MPI are shown in Figure 1 . Patients with abnormal S-MPI tended to have significantly more segments with stenosis. There was a tendency to have LMT lesions more frequently than in patients with normal S-MPI but the difference did not reach statistical significance. High-risk CAD as defined was seen in 14 (67%) of 21 patients with abnormal S-MPI (ie, was more frequent than the 10 (33%) of 30 patients with normal S-MPI). An Tables 3 and  4 . Among both patients with normal S-MPI and patients with abnormal S-MPI, there were no significant differences in all clinical characteristics, except the CCS, between patients with and without high risk CAD. The average calcium score of patients with high-risk CAD was significantly higher than that of patients without high-risk CAD. Tables 1-3 . Abbreviations see in Tables 1-3 . KIRIYAMA T et al.
Follow-up Results
Follow-up was completed in all 51 patients, excluding the 5 patients with poor CCTA study, and an event occurred in 5 patients (10%). The results of S-MPI and CCTA for the 5 patients who reached the clinical endpoint are shown in Table 5 . Death by any cause occurred in 1 patient (2%), nonfatal myocardial infarction occurred in 1 patient (2%), and 1 patient (2%) was hospitalized because of unstable angina. Among 30 patients with normal S-MPI, 8 underwent invasive coronary angiography (CAG), and 2 of the 8 patients underwent early elective revascularization [CABG (n=1), PCI (n=1)] <60 days after S-MPI and CCTA. Among the 21 patients with abnormal S-MPI, 16 underwent CAG, and 6 underwent early revascularization [CABG (n=1), PCI (n=5)].
Of the 2 patients (4%) with abnormal S-MPI, revascularization [PCI (n=2)] was performed >60 days after S-MPI and CCTA.
Discussion
A wide range of coronary atherosclerosis types and severities was observed in the study population whether S-MPI showed perfusion abnormalities or not. Non-obstructive (10%) and obstructive CAD (80%), as well as high CCS (average 498± 652) as determined by CCTA, were associated with normal S-MPI. This result indicates that subclinical coronary atherosclerosis is progressing even when myocardial perfusion is still normal. Moreover, high-risk CAD, defined as occlusive LMT lesion or 3-vessel disease, was detected in one-third of patients with normal S-MPI, although there was a tendency for patients with abnormal S-MPI to have more segments with stenosis and high-risk CAD more frequently than patients with normal S-MPI. The relation between S-MPI and CCTA results has been investigated in several previous studies. The study of van Werkhoven et al was partially in line with our results. Analyzing 97 patients with normal S-MPI, patients with non-obstructive and obstructive CAD accounted for 37% and 23%, respectively. 17 Schuijf et al reported similar results. 18 In their study, non-obstructive and obstructive CAD accounted for 40% and 12%, respectively, among 77 patients with normal S-MPI. They also reported an average calcium score for patients with normal S-MPI as 162±332, which was even significantly lower than that for patients with abnormal S-MPI, and 41% of patients with normal S-MPI had CCS >400. The available evidence indicates normal S-MPI results are associated with a wide range of coronary atherosclerosis morphologies and high CCS, and cannot be used to rule out the presence of atherosclerosis.
On the other hand, unlike our results, van Werkhoven et al concluded that a high risk of CAD such as 3-vessel disease and LMT lesions was very rare (4%) in patients with normal S-MPI. 17 However, this disagreement might be explained by a difference in study populations. In our study population, approximately half of the patients had an intermediate pretest risk and the other half had a high pretest risk or known CAD, whereas the other study's population consisted of mostly intermediate-risk patients. Thus, in a relatively high pretest risk population like ours, the potential existence of underlying high-risk CAD behind normal myocardial perfusion should be kept in mind, because S-MPI testing is generally recommended for use in intermediate-to high-risk patients.
During follow-up, an event occurred in 5 (10%) patients. Excluding revascularization based on the results of both tests, all 3 (6%) patients with hard events were diagnosed as highrisk CAD by CCTA, whereas 1 (2%) of the 3 patients had normal S-MPI results. Based on the available evidence, however, a normal S-MPI result is associated with an excellent long-term prognosis and an annual hard event rate <1%. 19-21 Hence, our results suggest that applying the evidence to a high-risk population should be carefully considered. van Werkhoven et al recently reported the relation between CCTA and S-MPI regarding prognosis. 22 The cardiac event rate in those having more than 1 stenosis (>50%) diagnosed by CCTA (3.8%), even if S-MPI was normal, was almost equivalent to that of subjects with abnormal S-MPI results (3.7%). Although further evidence of the relation between CCTA and S-MPI regarding prognosis is needed, the information about coronary atherosclerosis obtained with CCTA may provide additional value that is useful for cardiac risk stratification by S-MPI.
Among patients with normal S-MPI in our population, any clinical risk factor was not significantly different between patients with and without high-risk CAD other than total calcium score, which reflects the severity of coronary atherosclerosis and contributes to risk stratification. A larger cohort study is expected to elucidate that some other clinical risk factors (eg, diabetes mellitus or hypercholesterolemia) would be a good measure to distinguish patients with high-risk CAD.
S-MPI occasionally underestimates perfusion abnormalities in patients with LMT lesions or balanced 3-vessel disease, so our S-MPI results possibly include false negatives. However, the combination of perfusion abnormalities and non-perfusion variables, such as increased lung uptake, postischemic stunning, and TID, improve the diagnostic accuracy of S-MPI for patients with LMT lesions or balanced disease. 23 Our S-MPI interpretation was performed with reference to LV functions, especially postischemic stunning or TID using the QGS. Moreover, the rare occurrence of false negative S-MPI for LMT lesion or 3-vessel disease, with a frequency of around 2% of normal S-MPI, has been reported. 24, 25 Among the 31 patients with normal S-MPI in our study, postischemic stunning was observed in only 1 (3%) patient with 3-vessel disease as identified by CCTA.
Study Limitations
First, no direct comparison between CCTA and invasive coronary angiography was performed to evaluate the diagnostic accuracy of CCTA in the present study. Thus, some stenoses with severe calcified plaque might be overestimated because of blooming artifacts. Furthermore, 5 patients (9%) whose CCTA images could not be interpreted due to motion artifacts and severe coronary calcification, also need to be excluded, although 64-slice CT has adequate diagnostic value for coronary stenosis, as previously reported. 26 Second, our S-MPI interpretation was performed only visual scoring without any quantitative perfusion analysis using a normal database. However, using SPECT images (short, vertical-long and horizontal-long-axis slices) with reference to the polar maps including ECG-gated LV functional analyses (eg, wall motion and thickening), and using SPECT/CT fusion analysis can avoid the possibility of misinterpretation. Third, our cohort was too small to assess the outcomes and was heterogeneous, consisting of both suspected and known CAD, as well as including patients with a history of myocardial infarction and previous PCI. Further studies, including outcomes, must be conducted to evaluate the relation between the prognostic roles of CCTA and S-MPI in larger and more homogeneous populations. Finally, the radiation burden of CCTA Discordance Between Coronary CTA and Stress MPI in addition to S-MPI is another limitation. However, the radiation dose can be significantly decreased by using dedicated dose-reduction CT acquisition techniques that have recently become available.
Conclusions
A normal S-MPI result can reflect a wide range of coronary atherosclerosis types and severities and, to some extent, involves severe coronary atherosclerosis like LMT lesion and 3-vessel disease in patients with an intermediate to high probability of CAD. Complementary assessment including coronary morphological information by CCTA might partially modify the traditional risk stratification by S-MPI.
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